PK/PD analysis and proper dosage of antimicrobial agents for effective and safe treatment of infectious diseases

Yakugaku Zasshi

Volumn 127, Issue 6, 2007, Pages 931-937

  Hori, Seiji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adverse effect; Antimicrobial agent; Dosage; Pharmacokinetics pharmacodynamics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BIAPENEM; CARBEPENEM; CEFAZOLIN; CEFTAZIDIME; CEPHEM; CIPROFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; LOMEFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PANIPENEM; PAZUFLOXACIN; PENICILLIN DERIVATIVE; PURLIFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; TELITHROMYCIN; TOSUFLOXACIN; UNCLASSIFIED DRUG;

ALLERGIC REACTION; BACTERIAL INFECTION; BLEEDING; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG USE; HUMAN; HYPOGLYCEMIA; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; NEPHROTOXICITY; OTOTOXICITY; PHARMACIST; PHARMACODYNAMICS; REVIEW; SEIZURE;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOXICITY; HUMANS;

EID: 34249797297     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.931     Document Type: Review

References (23)

1. Nicolau D. P., J. Infect. Chemother., 9, 292-296 (2003).
2. Hori S., Antibiot. Chemother., 19, 528-538 (2003).
3. Vogelman B., Gudmundsson S., Leggett J., Turnidge J., Ebert S., Craig W. A., J. Infect. Dis., 158, 831-847 (1988).
4. Drusano G. L., Craig W. A., J. Chemother., 9 (Suppl 3), 38-44 (1997).
5. Andes D., Craig W. A., Antimicrob. Agents Chemother., 46, 1665-1670 (2002).
6. DeRyke C. A., Lee S. Y., Kuti J. L., Nicolau D. P., Drugs, 66, 1-14 (2006).
7. Andes D., Craig W. A., "Understanding Pharmacokinetics and Pharmacodynamics: Application to the Antimicrobial Formulary Decision Precess. Antibiotic Optimization," eds. by Owens Jr. R. C., Ambrose P. G., Nightingale C. H., Marcel Dekker, New York, 2005.
8. Hori S., "Koukinyaku Touyo no Kagaku," eds. by Sunakawa K., Totsuka K., Medicine and Drug Journal Co., Ltd., Osaka, 1998, pp. 58-72.
9. Hori S., Jpn. J. Chemother., 52, 293-303 (2004).
10. Hori S., Ogino H., J. Med. Technol., 50, 23-39 (2006).
11. Horioka M., "Principles and Practice of Dispensing Pharmacy," 5th ed., by Nanzando Co., Ltd., Tokyo, 2001.
12. Morita K., Shimada M., Ikeya O., Yamayoshi Y., Tanigawara Y., Kobayashi Y., Sugita K., Jpn. J. Ther. Drug Monit., 20, 189-190 (2003).
13. Shimada J., Hori S., Kanemitsu K., Shoji Y., Nakashio S., Yanagawa A., Drugs Exptl. Clin. Res., 18, 377-381 (1992).
14. Calandra G., Lyock E., Carrigan J., Weiss L., Guess H., Am. J. Med., 84, 911-918 (1988).
15. Gilbert D. N., "Aminoglycosides, Mandell, Douglas, and Bennett's Principle and Practice of Infectious Diseases," eds. by Mandell G. L., Bennett J. E., Dolin R., Chuchill Livingstone, Philadelphia, 2000, pp. 307-336.
16. Quintiliani Jr. R., Quintiliani R., Nightingale C. H., "Aminoglycosides, Infectious Diseases 2nd," eds. by Cohen J., Powderly W. G., Mosby, Edinburgh, 2004, pp. 1809-1818.
17. Shimizu K., Aikawa N., Tanigawara Y., Kaku M., Imae M., Nishizawa N., Nakamura H., Jpn. J. Chemother., 51, 717-730 (2003).
18. Sato R., Tanigawara Y., Morita K., Kaku M., Aikawa N., Shimizu K., Jpn. J. Clin. Pharmacol. Ther., 35, 91S-92S (2004).
19. Morita K., Pharmac. Monthly, 46, 2157-2163 (2004).
20. Hori S., Kizu J., Kawamura M., J. Infect. Chemother., 9, 314-320 (2003).
21. Ministry of Health, Labour and Welfare, Pharmaceuticals and Medical Devices Safety Information No. 188, 10-16 (2003).
22. Tamayama T., Tanaka Y., Saito A., Jpn. J. Chemother., 52, 521-529 (2004).
23. Hori S., Kizu J., Kawamura M., J. Infect. Chemother., 12, 109-111 (2006).